Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 632 | 506 | 585 | 382 | 270 |
| Income taxes - deferred | N/A | N/A | N/A | 1,967 | 2,242 |
| Accounts receivable | -5 | 877 | 897 | -1,271 | -338 |
| Other Working Capital | 27,646 | 1,159 | 2,312 | -665 | -1,664 |
| Other Operating Activity | -26,008 | -23,808 | -16,767 | -12,833 | -12,739 |
| Operating Cash Flow | $2,264 | $-21,267 | $-12,972 | $-12,419 | $-12,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -165 | -234 | -607 | -1,249 |
| Purchase Of Investment | -19,667 | -6,345 | -6,650 | -5,304 | N/A |
| Sale Of Investment | 0 | 405 | 24,492 | 0 | 7,408 |
| Purchase Sale Intangibles | 0 | -74 | 0 | -56 | -10 |
| Other Investing Activity | -8 | 49 | -20 | 199 | 259 |
| Investing Cash Flow | $-19,687 | $-6,129 | $17,587 | $-5,768 | $6,408 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,914 | 433 | 65 | 0 | 58,005 |
| Common Stock Repurchased | N/A | N/A | 0 | -125 | N/A |
| Financing Cash Flow | $6,914 | $433 | $65 | $-125 | $58,005 |
| Exchange Rate Effect | 47 | -3 | 365 | 2,402 | -256 |
| Beginning Cash Position | 28,182 | 54,239 | 52,721 | 64,043 | 24,974 |
| End Cash Position | 17,720 | 27,274 | 57,766 | 48,133 | 76,900 |
| Net Cash Flow | $-10,509 | $-26,963 | $4,680 | $-18,312 | $52,183 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,264 | -21,267 | -12,972 | -12,419 | -12,230 |
| Capital Expenditure | -12 | -239 | -234 | -663 | -1,259 |
| Free Cash Flow | 2,253 | -21,505 | -13,206 | -13,082 | -13,489 |